Study of Indomethacin Capsules to Treat Pain Following Bunionectomy

NCT01626118 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 373

Last updated 2014-03-17

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine whether Indomethacin \[Test\] Capsules are safe and effective for the treatment of postoperative bunionectomy pain.

Conditions

  • Other Acute Postoperative Pain

Interventions

DRUG

Indomethacin

capsules, 40 mg, TID

DRUG

Indomethacin

capsules, 40 mg, BID

DRUG

Indomethacin

capsules, 20 mg, TID

DRUG

Placebo

capsules

Sponsors & Collaborators

  • Iroko Pharmaceuticals, LLC

    lead INDUSTRY

Principal Investigators

  • Jason Dickerson, DPM · Premier Research Group Limited

  • Michael Golf, DPM · Premier Research Group Limited

  • Ira Gottlieb, DPM · Chesapeake Research Group, LLC

  • Kyle Patrick, DO · Premier Research Group Limited

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-05-31
Primary Completion
2012-08-31
Completion
2012-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01626118 on ClinicalTrials.gov